Accumulation of plasmacytoid dendritic cell is associated with a treatment response to DNA-damaging treatment and favorable prognosis in lung adenocarcinoma
IntroductionFavorable responses to the treatment including immune checkpoint inhibitors (ICIs) have been consistently reported in lung cancer with smoking history. As the tumor microenvironment (TME) may be involved in the treatment response to ICIs, we aimed to investigate the TME of lung cancer wi...
Main Authors: | Yoon Jin Cha, Eun Young Kim, Yong Jun Choi, Chi Young Kim, Min Kyung Park, Yoon Soo Chang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-06-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1154881/full |
Similar Items
-
Plasmacytoid dendritic cells contribute to vascular endothelial dysfunction in type 2 diabetes
by: K. Alluri, et al.
Published: (2023-11-01) -
Human Plasmacytoid Dendritic Cells and Cutaneous Melanoma
by: Matilde Monti, et al.
Published: (2020-02-01) -
The Expression of Plasmacytoid Dendritic Cells and TLR7/9-MyD88-IRAKs Pathway in Chronic Eczema Lesions
by: Wen J, et al.
Published: (2023-04-01) -
The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy
by: Wayne Croft, et al.
Published: (2022-10-01) -
Transcriptional regulation of dendritic cell development and function
by: Shengbo Zhang, et al.
Published: (2023-07-01)